Skip to content

Advanced Image Guidance Utilized in Liver Surgery

Advanced Image Guidance for Ablation Probe Placement in Laparoscopic Liver Surgery: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01666145
Enrollment
14
Registered
2012-08-16
Start date
2012-02-29
Completion date
2014-02-28
Last updated
2022-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Hepatocellular

Keywords

Hepatocellular Cancer, Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult, Liver Cell Carcinoma, Adult

Brief summary

Advanced Image Guidance for this study was used during laparoscopic microwave ablation surgery to help the surgeon accurately place the ablation needle into the tumor of patients diagnosed with liver cancer.

Detailed description

Hepatocellular carcinoma (HCC) is diagnosed in over 19,000 Americans annually and responsible for 17,000 deaths. Worldwide, (HCC) is the third leading cause of cancer death. Hepatocellular carcinoma recurs frequently due to its multi-centric nature, which requires repeated treatments and often results in progressively fewer treatment options because of severe underlying liver dysfunction. While surgery offers the best prognosis for such tumors and lesions, only 10-15% of all patients are candidates for removal by surgical means, necessitating the exploration of other treatment options. InnerOptic's AIM Guidance System is designed to alleviate the difficulty in using ultrasound to place a needle. AIM shows the needle and the ultrasound slice in their locations in 3D on a stereo monitor, making the spatial relationship between them obvious. AIM also displays the needle trajectory and where the needle will intersect with the ultrasound image, providing the surgeon with an indication of where the needle will go, if inserted along the needle shaft. AIM can also render an ablation volume guide, providing the surgeon with further confirmation that the needle is placed accurately and providing a volumetric guide regarding the power settings of the ablation.

Interventions

DEVICEAdvanced Image Guidance

Patients with hepatocellular carcinoma will be treated through laparoscopic microwave ablation surgery, in which the surgeon will utilize a new guidance system for needle placement.

Sponsors

InnerOptic
CollaboratorUNKNOWN
Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Individuals who have hepatocellular carcinoma. * Individuals who are candidates for microwave ablation surgery.

Exclusion criteria

* Individuals who do not have hepatocellular carcinoma. * Individuals who are not a candidate for laparoscopic microwave ablation surgery.

Design outcomes

Primary

MeasureTime frameDescription
Successful Insertion of Ablation Antenna Into Target LesionParticipants will be followed for the duration of hospital stay, an expected average of 2 to 3 days.Once the ablation antenna has been placed into the target lesion, the success or failure of the attempt will be confirmed with conventional ultrasound alone, in two planes. If the placement is deemed successful, the surgeon will commence the ablation of the tumor. If the placement is deemed insufficient, the probe will be removed and another placement will be attempted using conventional guidance.

Secondary

MeasureTime frameDescription
Percentage of Participants With Significant Ease of Lesion Targeting Using Advanced Image Guidance (AIM)Participants will be followed for the duration of hospital stay, an expected average of 2 to 3 days.A subjective grading scale from which the surgeon will provide the relative ease of lesion targeting using Advanced Image Guidance (AIM) and the guidance system; the scale will be numbered 1-5 with one being significantly difficult and five being significantly easy. The percentage of participants with a score of 5 is reported below.

Countries

United States

Participant flow

Participants by arm

ArmCount
Intraoperative Imaging
Laparoscopic microwave ablation surgery utilizing the Advanced Image Guidance system for needle placement. Advanced Image Guidance: Patients with hepatocellular carcinoma will be treated through laparoscopic microwave ablation surgery, in which the surgeon will utilize a new guidance system for needle placement.
14
Total14

Baseline characteristics

CharacteristicIntraoperative Imaging
Age, Continuous63 years
Region of Enrollment
United States
14 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 14
other
Total, other adverse events
0 / 14
serious
Total, serious adverse events
0 / 14

Outcome results

Primary

Successful Insertion of Ablation Antenna Into Target Lesion

Once the ablation antenna has been placed into the target lesion, the success or failure of the attempt will be confirmed with conventional ultrasound alone, in two planes. If the placement is deemed successful, the surgeon will commence the ablation of the tumor. If the placement is deemed insufficient, the probe will be removed and another placement will be attempted using conventional guidance.

Time frame: Participants will be followed for the duration of hospital stay, an expected average of 2 to 3 days.

ArmMeasureValue (NUMBER)
Intraoperative ImagingSuccessful Insertion of Ablation Antenna Into Target Lesion100 percentage of participants
Secondary

Percentage of Participants With Significant Ease of Lesion Targeting Using Advanced Image Guidance (AIM)

A subjective grading scale from which the surgeon will provide the relative ease of lesion targeting using Advanced Image Guidance (AIM) and the guidance system; the scale will be numbered 1-5 with one being significantly difficult and five being significantly easy. The percentage of participants with a score of 5 is reported below.

Time frame: Participants will be followed for the duration of hospital stay, an expected average of 2 to 3 days.

ArmMeasureValue (NUMBER)
Intraoperative ImagingPercentage of Participants With Significant Ease of Lesion Targeting Using Advanced Image Guidance (AIM)100 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026